The rates of lipolysis in white adipose tissue are increased in NASH patients2, and hepatic free fatty acid uptake is also increased in NAFL and NASH due to the increased expression of CD363. The gene discussed is S1PR1; the disease is metabolic dysfunction-associated steatohepatitis.